Business Context and Reporting Period
Company: Purple Innovation, Inc. (PRPL)
Filing Type: Form 8-K (Current Report)
Date of Report: April 19, 2023
Event: Entry into a Cooperation Agreement with Coliseum Capital Management, LLC to resolve a contested proxy solicitation and related litigation regarding the 2023 Annual Meeting of stockholders.
Key Financial Metrics
This filing is a current report regarding corporate governance and legal settlements. It does not contain financial statements, revenue, profit, cash flow, or debt metrics. The only specific financial figure disclosed is a reimbursement cap for legal expenses.
- Legal Expense Reimbursement Cap: The Company agreed to reimburse Coliseum for out-of-pocket fees and expenses related to the litigation, not to exceed $4 million in the aggregate.
Material Changes Versus Prior Period
The filing details significant changes to the Company's corporate governance structure and security holder rights effective upon the "Effective Time" of the Cooperation Agreement:
- Board Composition: The Board size increased from 7 to 8 directors. Pano Anthos and Paul Zepf resigned. S. Hoby Darling, R. Carter Pate, and Erika Serow were appointed as new directors. Adam Gray was appointed Chair of the Board.
- Committee Leadership: Gary DiCamillo was appointed Chair of the Nomination & Governance Committee and will continue as Lead Independent Director.
- Security Rights: The stockholder rights agreement adopted on September 25, 2022, was terminated. All outstanding shares of Proportional Representation Preferred Linked Stock (PRPLS) were redeemed.
- Bylaws: The Company amended and restated its bylaws to reflect the new governance structure, including the Lead Independent Director Charter.
Guidance, Outlook, Risks, and Unusual Items
Management Commentary and Agreements:
- Standstill Agreement: Coliseum agreed to customary standstill restrictions, limiting its ownership of Voting Securities to 44.4% and prohibiting proxy solicitations or forming groups to contest the Board, subject to exceptions.
- Future Acquisitions: Any proposal by Coliseum to acquire the Company must be negotiated by an independent special committee and approved by a majority of stockholders not affiliated with Coliseum.
- Voting Commitment: Coliseum agreed to vote its shares in favor of the Company's slate of nominees at the 2023 and 2024 Annual Meetings and against any stockholder nominations or removal proposals (except for cause).
- Termination of Litigation: The parties agreed to release claims and dismiss the action Coliseum Capital Management, LLC v. DiCamillo et al.
Risks and Contingencies:
- The Cooperation Agreement will terminate if the Effective Time does not occur by 5:00 p.m. New York City time on April 28, 2023, or on the day following the 2024 Annual Meeting.
Important Facts for Investor Verification
- Verify the execution of the PRPLS redemption and the termination of the stockholder rights agreement.
- Confirm the final composition of the Board of Directors and the appointment of Adam Gray as Chair.
- Monitor the filing of the stipulation of dismissal for the Coliseum Capital Management, LLC v. DiCamillo et al. litigation.
- Review the Third Amended and Restated Bylaws (Exhibit 3.1) for specific changes to governance procedures.
- Track the $4 million cap on legal expense reimbursements to Coliseum.